Free Trial
NASDAQ:CMND

Clearmind Medicine (CMND) Stock Price, News & Analysis

Clearmind Medicine logo
$1.40
+0.04 (+2.94%)
(As of 11/4/2024 ET)

About Clearmind Medicine Stock (NASDAQ:CMND)

Key Stats

Today's Range
$1.33
$1.45
50-Day Range
$1.20
$1.76
52-Week Range
$0.92
$6.80
Volume
87,792 shs
Average Volume
1.41 million shs
Market Capitalization
$2.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors. The company also develops MEAI compound which is in IND-enabling study for the treatment of alcohol use disorder; and is in pre-clinical study for treatment of obesity, weight loss, metabolic disorder, and addiction. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; and with Yissum Research Development Company of the Hebrew University of Jerusalem for the discovery and development of novel psychedelic-derived therapeutics to treat mental disorders. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Clearmind Medicine Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
6th Percentile Overall Score

CMND MarketRank™: 

Clearmind Medicine scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Book Value per Share Ratio

    Clearmind Medicine has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.22% of the float of Clearmind Medicine has been sold short.
  • Short Interest Ratio / Days to Cover

    Clearmind Medicine has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Clearmind Medicine has recently increased by 7.94%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Clearmind Medicine does not currently pay a dividend.

  • Dividend Growth

    Clearmind Medicine does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.22% of the float of Clearmind Medicine has been sold short.
  • Short Interest Ratio / Days to Cover

    Clearmind Medicine has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Clearmind Medicine has recently increased by 7.94%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    4 people have searched for CMND on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Clearmind Medicine to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Clearmind Medicine insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    96.05% of the stock of Clearmind Medicine is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Clearmind Medicine's insider trading history.
Receive CMND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clearmind Medicine and its competitors with MarketBeat's FREE daily newsletter.

CMND Stock News Headlines

Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Clearmind Medicine patents new addiction treatment
See More Headlines

CMND Stock Analysis - Frequently Asked Questions

Clearmind Medicine's stock was trading at $2.81 on January 1st, 2024. Since then, CMND stock has decreased by 50.2% and is now trading at $1.40.
View the best growth stocks for 2024 here
.

Clearmind Medicine Inc. (NASDAQ:CMND) announced its earnings results on Monday, September, 16th. The company reported ($0.59) earnings per share (EPS) for the quarter.

Clearmind Medicine's stock reverse split on Tuesday, November 28th 2023. The 1-30 reverse split was announced on Tuesday, November 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Clearmind Medicine (CMND) raised $9 million in an initial public offering on Tuesday, November 15th 2022. The company issued 1,300,000 shares at $6.00-$8.00 per share. Aegis Capital Corp. served as the underwriter for the IPO.

Shares of CMND stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clearmind Medicine investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), Meta Platforms (META), AppLovin (APP) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
9/16/2024
Today
11/04/2024
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CMND
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-8,620,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.22 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.37 million
Optionable
Not Optionable
Beta
1.26
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:CMND) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners